…查看全文
$阿莱克萨制药(ALXA)$ SC 14D9/A [Amend] - Solicitation, recommendation statements Filed: 2016-06-21 AccNo: 0001193125-16-627171 Size: 42 KB 网页链接
$阿莱克萨制药(ALXA)$ 内部交易: 2016-06-21,10% Owner,Grupo Ferrer Internacional, S. ,买入,19465714普通股, $0.90
$阿莱克萨制药(ALXA)$ 8-K - Current report Filed: 2016-06-16 AccNo: 0001193125-16-623623 Size: 17 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$阿莱克萨制药(ALXA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-06-16 AccNo: 0000921895-16-004953 Size: 81 KB 网页链接
$阿莱克萨制药(ALXA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-06-16 AccNo: 0000921895-16-004953 Size: 81 KB 网页链接
$阿莱克萨制药(ALXA)$ 8-K - Current report Filed: 2016-06-16 AccNo: 0001193125-16-623623 Size: 17 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$阿莱克萨制药(ALXA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-06-16 AccNo: 0000921895-16-004953 Size: 81 KB 网页链接
$阿莱克萨制药(ALXA)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2016-06-15 AccNo: 0001341004-16-001499 Size: 48 KB 网页链接
$阿莱克萨制药(ALXA)$ SD - Filed: 2016-06-15 AccNo: 0001193125-16-622488 Size: 27 KB 网页链接
$阿莱克萨制药(ALXA)$ SC 14D9/A [Amend] - Solicitation, recommendation statements Filed: 2016-06-13 AccNo: 0001193125-16-620137 Size: 107 KB 网页链接